Emory Nursing School Receives $3.3 Million Grant to Study Head and Neck Cancer Immunotherapy
September 20, 2024
September 20, 2024
ATLANTA, Georgia, Sept. 20 (TNSres) -- Emory University issued the following news release:
Since immunotherapy has been approved by the Food and Drug Administration to treat advanced head and neck cancer (HNC), it has offered patients new hope - and new challenges.
Many patients with HNC suffer psychosocial burdens before immunotherapy, likely due to disease- and treatment-induced side effects that can impact daily functions such as eating and speaking. Immunotherapy ma . . .
Since immunotherapy has been approved by the Food and Drug Administration to treat advanced head and neck cancer (HNC), it has offered patients new hope - and new challenges.
Many patients with HNC suffer psychosocial burdens before immunotherapy, likely due to disease- and treatment-induced side effects that can impact daily functions such as eating and speaking. Immunotherapy ma . . .